Oruka Therapeutics, Inc. · NASDAQ:ORKA
Dambkowski Carl sold 35,000 Oruka Therapeutics, Inc. shares (Form 4)
Traded Jun 11 to Jun 12, 2026 · Filed Jun 12, 2026
From Jun 11 to Jun 12, 2026, Dambkowski Carl (Director) sold 35,000 Oruka Therapeutics, Inc. shares at an average US$70.12 for US$2.45M under a trading plan, leaving 38,743 shares. Filed Jun 12, 2026 (Form 4).
- Sold
- 35,000 shares
- Price
- US$70.12 average (US$70.11 to US$70.13)
- Value
- US$2.45M
- Holding after
- 38,743 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 11, 2026 | Common Stock | Sale | 22,417 | US$70.13 | 51,326 | Direct |
| Jun 12, 2026 | Common Stock | Sale | 12,583 | US$70.11 | 38,743 | Direct |
Source
Related
- Oruka Therapeutics, Inc.
- Dambkowski Carl
- Oruka Therapeutics, Inc. shareholders
- Form 4 · Dambkowski Carl · May 22, 2026
- Form 4 · Quinlan Paul T · Oct 20, 2026
- Form 4 · Goncalves Joana · Oct 15, 2026
- Form 4 · Agarwal Arjun · Oct 13, 2026
- Form 4 · Klein Lawrence Otto · Oct 2, 2026
- Form 4 · Quinlan Paul T · Sep 21, 2026